|
시장보고서
상품코드
1787016
대조약 소싱 시장 : 규모, 점유율, 동향, 산업 분석 보고서 - 유형별, 용도별, 지역별, 시장 예측(2025-2034년)Comparator Drug Sourcing Market Size, Share, Trends, & Industry Analysis Report By Type (Local Sourcing, Central Sourcing, and Market Sourcing), By Application, and By Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면 대조약 소싱 시장 규모는 2034년까지 22억 2,000만 달러에 이를 것으로 예측됩니다. 이 보고서는 현재 시장 역학을 상세하게 파악하고 미래 시장 성장에 대한 분석을 제공합니다.
대조약 소싱은 기존 표준 치료에 대한 새로운 치료제의 안전성과 효능을 평가하는 임상시험에서 필수적입니다. 이러한 약물은 규정 준수, 배치 추적성, 시험 실시 시설에 대한 적시의 세계 전달을 보장하는 전문 공급자를 통해 조달됩니다.
시장 성장의 주요 원동력은 세계의 임상 시험 건수 증가와 약물의 추적성 및 품질 컴플라이언스에 관한 규제 당국의 감시 강화입니다. 제약 스폰서 및 의약품 개발 업무 수탁기관(CRO)의 서비스는 집중형 및 현지화된 조달 모델을 제공하고, 공급의 연속성, 문서의 정확성, 국경을 넘은 컴플라이언스를 확보하는 소싱 파트너에 대한 의존도가 높아지고 있습니다.
대조약 소싱 시장 보고서 하이라이트
유형별로는 조달 표준화, 법규 규정 준수 개선, 대규모 3상 임상시험 지원이 가능한 중앙 조달 부문이 2024년 시장을 독점했습니다.
용도별로는 제조수탁기관(CMO) 분야가 2024년 시장을 독점했습니다. 이 배경에는 임상시험의 아웃소싱 증가와 계약 기반 임상 시행에서 턴키 소싱 솔루션의 필요성이 있습니다.
북미는 임상 시험량이 많고, 엄격한 FDA 컴플라이언스 요건, 집중형 소싱 모델에 대한 강한 의존성으로 2024년 세계 대조약 소싱 시장의 대부분의 점유율을 차지했습니다.
아시아태평양은 임상시험 확대, 비용 우위성, 지역 인프라 성장으로 큰 시장 점유율을 차지하고 있습니다.
세계 주요 시장 기업은 Thermo Fisher Scientific Inc., Clinigen Limited, Incceptua Group, Uniphar Clinical, Catalent, Inc., Clinical Services International(CSI), BAP Pharma Limited, Oximio, Bionic Emas, Alcura, Myonex, Cencora, Inc., Sharp Services, LLC, ADAllen Pharma, RxSolutions 부문 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 대조약 소싱 시장 인사이트
- 시장 현황
- 대조약 소싱 시장 역학
- 성장 촉진요인 및 기회
- 증가하는 세계의 임상시험
- 엄격한 규제 요건
- 성장 억제요인 및 과제
- 온도 관리 물류에 따른 높은 운영 비용
- 성장 촉진요인 및 기회
- PESTEL 분석
- 대조약 소싱 시장 동향
- 밸류체인 분석
제5장 세계의 대조약 소싱 시장 : 유형별
- 주요 조사 결과
- 서문
- 중앙 조달
- 현지 조달
- 기타 유형
제6장 세계의 대조약 소싱 시장 : 용도별
- 주요 조사 결과
- 서문
- 의약품 제조업자
- 수탁 제조 조직(CMO)
- 학술연구기관
- 기타 용도
제7장 세계의 대조약 소싱 시장 : 지역별
- 주요 조사 결과
- 서문
- 대조약 소싱 시장 평가 : 지역별(2020-2034년)
- 북미
- 북미 : 유형별(2020-2034년)
- 북미 : 용도별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 유형별(2020-2034년)
- 유럽 : 용도별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 유형별(2020-2034년)
- 아시아태평양 : 용도별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 유형별(2020-2034년)
- 중동 및 아프리카 : 용도별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 유형별(2020-2034년)
- 라틴아메리카 : 용도별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제8장 경쟁 구도
- 확대 및 인수 분석
- 확대
- 인수
- 제휴, 협업, 합의 및 공개
제9장 기업 프로파일
- Alcura
- ADAllen Pharma
- BAP Pharma Limited
- Bionical Emas
- Catalent, Inc.
- Cencora, Inc.
- Clinical Services International(CSI)
- Clinigen Limited
- Inceptua Group
- Myonex
- Oximio
- RxSolutions division
- Sharp Services, LLC
- Thermo Fisher Scientific Inc.
- Uniphar Clinical
The comparator drug sourcing market size is expected to reach USD 2.22 Billion by 2034, according to a new study by Polaris Market Research. The report "Comparator Drug Sourcing Market Share, Size, Trends, Industry Analysis Report: By Type (Local Sourcing, Central Sourcing, and Market Sourcing), By Application, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Comparator drugs are essential in clinical trials to evaluate the safety and efficacy of new therapeutics against existing standards of care. These drugs are sourced through specialized providers that ensure regulatory compliance, batch traceability, and timely global delivery across trial sites.
Market growth is primarily driven by the rising number of global clinical trials globally coupled with growing regulatory scrutiny around drug traceability and quality compliance. Pharmaceutical sponsors and contract research organization (CROs) services are increasingly relying on sourcing partners that offer centralized and localized procurement models, ensuring supply continuity, documentation accuracy, and cross-border compliance.
Comparator Drug Sourcing Market Report Highlights
Based on type, the central sourcing segment dominated the market in 2024, owing to its ability to standardize procurement, improve regulatory compliance, and support large-scale Phase III clinical trials.
In terms of application, the contract manufacturing organizations (CMO) segment dominated the market in 2024. This is fueled by increasing trial outsourcing and the need for turnkey sourcing solutions within contract-based clinical execution.
North America accounted for the majority share of the global comparator drug sourcing market in 2024, fueled by high clinical trial volume, stringent FDA compliance requirements and strong reliance on centralized sourcing models.
Asia Pacific held significant market share, driven by expanding trial activity, cost advantages, and growing regional infrastructure.
A few global key market players include Thermo Fisher Scientific Inc., Clinigen Limited, Inceptua Group, Uniphar Clinical, Catalent, Inc, Clinical Services International (CSI), BAP Pharma Limited, Oximio, Bionical Emas, Alcura, Myonex, Cencora, Inc., Sharp Services, LLC, ADAllen Pharma, and RxSolutions division.
Polaris Market Research has segmented the market report on the basis of type, application, and region:
By Type Outlook (Revenue, USD Billion, 2020-2034)
Central Sourcing
Local Sourcing
Other Types
By Application Outlook (Revenue, USD Billion, 2020-2034)
Drug Producers/Manufacturers
Contract Manufacturing Organizations (CMO)
Academic and Research Institute
Other Applications
By Regional Outlook (Revenue, USD Billion, 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Comparator Drug Sourcing Market Insights
- 4.1. Comparator Drug Sourcing Market - Market Snapshot
- 4.2. Comparator Drug Sourcing Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Growing Number of Global Clinical Trials
- 4.2.1.2. Stringent Regulatory Requirements
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Operational Costs Associated with Temperature-Controlled Logistics
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Comparator Drug Sourcing Market Trends
- 4.6. Value Chain Analysis
5. Global Comparator Drug Sourcing Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 5.3. Central Sourcing
- 5.3.1. Global Comparator Drug Sourcing Market, by Central Sourcing, by Region, 2020-2034 (USD Billion)
- 5.4. Local Sourcing
- 5.4.1.1. Global Comparator Drug Sourcing Market, by Local Sourcing, by Region, 2020-2034 (USD Billion)
- 5.4.2. Global Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 5.5. Other Types
- 5.5.1.1. Global Comparator Drug Sourcing Market, by Other Types, by Region, 2020-2034 (USD Billion)
6. Global Comparator Drug Sourcing Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 6.3. Drug Producers/Manufacturers
- 6.3.1. Global Comparator Drug Sourcing Market, by Drug Producers/Manufacturers, by Region, 2020-2034 (USD Billion)
- 6.4. Contract Manufacturing Organizations (CMO)
- 6.4.1. Global Comparator Drug Sourcing Market, by Contract Manufacturing Organizations (CMO), by Region, 2020-2034 (USD Billion)
- 6.5. Academic and Research Institute
- 6.5.1. Global Comparator Drug Sourcing Market, by Academic and Research Institute, by Region, 2020-2034 (USD Billion)
- 6.6. Other Applications
- 6.6.1. Global Comparator Drug Sourcing Market, by Other Applications, by Region, 2020-2034 (USD Billion)
7. Global Comparator Drug Sourcing Market, by Geography
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Comparator Drug Sourcing Market Assessment, By Geography, 2020-2034 (USD Billion)
- 7.3. Comparator Drug Sourcing Market - North America
- 7.3.1. North America: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.3.2. North America: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.3.3. Comparator Drug Sourcing Market - U.S.
- 7.3.3.1. U.S.: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.3.3.2. U.S.: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.3.4. Comparator Drug Sourcing Market - Canada
- 7.3.4.1. Canada: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.3.4.2. Canada: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.4. Comparator Drug Sourcing Market - Europe
- 7.4.1. Europe: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.4.2. Europe: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.4.3. Comparator Drug Sourcing Market - UK
- 7.4.3.1. UK: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.4.3.2. UK: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.4.4. Comparator Drug Sourcing Market - France
- 7.4.4.1. France: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.4.4.2. France: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.4.5. Comparator Drug Sourcing Market - Germany
- 7.4.5.1. Germany: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.4.5.2. Germany: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.4.6. Comparator Drug Sourcing Market - Italy
- 7.4.6.1. Italy: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.4.6.2. Italy: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.4.7. Comparator Drug Sourcing Market - Spain
- 7.4.7.1. Spain: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.4.7.2. Spain: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.4.8. Comparator Drug Sourcing Market - Netherlands
- 7.4.8.1. Netherlands: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.4.8.2. Netherlands: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.4.9. Comparator Drug Sourcing Market - Russia
- 7.4.9.1. Russia: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.4.9.2. Russia: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.4.10. Comparator Drug Sourcing Market - Rest of Europe
- 7.4.10.1. Rest of Europe: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.4.10.2. Rest of Europe: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.5. Comparator Drug Sourcing Market - Asia Pacific
- 7.5.1. Asia Pacific: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.5.2. Asia Pacific: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.5.3. Comparator Drug Sourcing Market - China
- 7.5.3.1. China: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.5.3.2. China: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.5.4. Comparator Drug Sourcing Market - India
- 7.5.4.1. India: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.5.4.2. India: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.5.5. Comparator Drug Sourcing Market - Malaysia
- 7.5.5.1. Malaysia: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.5.5.2. Malaysia: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.5.6. Comparator Drug Sourcing Market - Japan
- 7.5.6.1. Japan: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.5.6.2. Japan: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.5.7. Comparator Drug Sourcing Market - Indonesia
- 7.5.7.1. Indonesia: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.5.7.2. Indonesia: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.5.8. Comparator Drug Sourcing Market - South Korea
- 7.5.8.1. South Korea: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.5.8.2. South Korea: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.5.9. Comparator Drug Sourcing Market - Australia
- 7.5.9.1. Australia: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.5.9.2. Australia: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.5.10. Comparator Drug Sourcing Market - Rest of Asia Pacific
- 7.5.10.1. Rest of Asia Pacific: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.5.10.2. Rest of Asia Pacific: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.6. Comparator Drug Sourcing Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.6.2. Middle East & Africa: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.6.3. Comparator Drug Sourcing Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.6.3.2. Saudi Arabia: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.6.4. Comparator Drug Sourcing Market - UAE
- 7.6.4.1. UAE: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.6.4.2. UAE: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.6.5. Comparator Drug Sourcing Market - Israel
- 7.6.5.1. Israel: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.6.5.2. Israel: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.6.6. Comparator Drug Sourcing Market - South Africa
- 7.6.6.1. South Africa: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.6.6.2. South Africa: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.6.7. Comparator Drug Sourcing Market - Rest of Middle East & Africa
- 7.6.7.1. Rest of Middle East & Africa: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.6.7.2. Rest of Middle East & Africa: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.7. Comparator Drug Sourcing Market - Latin America
- 7.7.1. Latin America: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.7.2. Latin America: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.7.3. Comparator Drug Sourcing Market - Mexico
- 7.7.3.1. Mexico: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.7.3.2. Mexico: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.7.4. Comparator Drug Sourcing Market - Brazil
- 7.7.4.1. Brazil: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.7.4.2. Brazil: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.7.5. Comparator Drug Sourcing Market - Argentina
- 7.7.5.1. Argentina: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.7.5.2. Argentina: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.7.6. Comparator Drug Sourcing Market - Rest of Latin America
- 7.7.6.1. Rest of Latin America: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.7.6.2. Rest of Latin America: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. Alcura
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. ADAllen Pharma
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. BAP Pharma Limited
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Bionical Emas
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Catalent, Inc.
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Cencora, Inc.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Clinical Services International (CSI)
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Clinigen Limited
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Inceptua Group
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Myonex
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. Oximio
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
- 9.12. RxSolutions division
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
- 9.13. Sharp Services, LLC
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
- 9.14. Thermo Fisher Scientific Inc.
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Recent Development
- 9.15. Uniphar Clinical
- 9.15.1. Company Overview
- 9.15.2. Financial Performance
- 9.15.3. Product Benchmarking
- 9.15.4. Recent Development
